Sanquin

Amsterdam, Netherlands Founded: 1998 • Age: 28 yrs
Foundation focused on blood collection and supply

About Sanquin

Sanquin is a Government & Social Sector company based in Amsterdam (Netherlands) founded in 1998. Foundation focused on blood collection and supply. Its chief executive, as recorded, is Ivo N. van Schaik. Sanquin offers products and services including Blood Products and Diagnostic Services. Its focus areas include Healthcare and Healthcare Foundations.

Company details

Sanquin was established in 1998 in Amsterdam, Netherlands, as a foundation in the healthcare sector specializing in blood services. Donors are recruited, and blood is processed into products including red blood cells, platelets, and plasma for direct delivery to hospitals. Research efforts are directed toward transfusion medicine, hematology, immunology, and cell therapy, with partnerships formed alongside national and international academic institutions.

Key Metrics
  • Latest Funding Round
    $206.64K (USD), Grant

    Sep 2022

  • Investors
    HHS

    & 1 more

Products & Services of Sanquin

Sanquin offers a comprehensive portfolio of products and services, including Blood Products and Diagnostic Services.

Blood Products
Medical Products

Blood products are supplied for transfusion and therapeutic purposes in healthcare settings.

Diagnostic Services
Laboratory Services

Diagnostic services are provided for tests like non-invasive fetal blood group genotyping and next-generation sequencing.

Apps and channels of Sanquin

its YouTube channel Sanquin has 2.47K subscribers and 30 videos.

Sanquin
YouTube 2.47K subscribers 30 videos Film & Animation
Open channel

Videos from Sanquin

The most watched videos on Sanquin's YouTube channel, Sanquin (2.47K subscribers). Click a video to play it here.

Welkom bij Sanquin!
5.4K views
Hoeveel bloedgroepen zijn er?
3.3K views
Waarom meten we je ferritine?
2.2K views
Sanquin Stories, Marco Koppelman, hoofd van NSS, vertelt over zijn werk.
1.4K views

More on Sanquin.

Funding Insights of Sanquin

  • Total Rounds 12
  • Last Round Grant β€” $206,638
  • First Round $1.7M

    (Jul 2008)

  • Investors Count 2

Latest 10 of 12 funding rounds of Sanquin with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2022$206,638Grant––
Jul 2020$491,635Grant––
Apr 2020$305,477Grant––
Jan 2020$938,695Grant––
Mar 2019$2.28MGrant––
May 2018$298,796Grant––
Jan 2018$1.09MGrant––
Sep 2017$197,633Grant––
Oct 2015$571,615Grant––
Sep 2015$576,789Grant––
Valuation history

2 investors in total: 2 institutional.

Investors in Sanquin

Sanquin has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and European Union.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Public health and human services are overseen by HHS.
1953hhs.gov
Premium access

Investor details for Sanquin

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Sanquin

1 people are tracked at Sanquin (1 in leadership).

NameRoleGroup
Ivo N. van Schaik
CEOLeadership
Premium access

Complete people profiles for Sanquin

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Sanquin

3 dated milestones of Sanquin across 24 years, from founding to its latest funding, stage changes and deals.

  1. Founded Sanquin is founded.
  2. Funding First funding round of $1.7M.
  3. Funding Latest funding round, Grant, of $207K.

Web traffic of Sanquin

The website of Sanquin (sanquin.org) receives about 9.3K visits a month.

  • Monthly visits
    9.3K

    ▼ 14.4% vs previous month

Similar websites

Websites whose visitors overlap most with Sanquin. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
ifmsa.nl
ifmsa.nl
100%
#2,526,883–
slingeland.nl
slingeland.nl
93%
#162,230–
nspoh.nl
nspoh.nl
88%
#463,441–
reuma.nl
reuma.nl
83%
#590,987–
europeanbloodalliance.eu
76%
View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 25 similar websites and full traffic analytics for Sanquin

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 25 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Sanquin

Sanquin was founded in 1998 and raised its 1st funding round 10 years after it was founded.

Sanquin is headquartered in Amsterdam, Netherlands.

Ivo N. van Schaik is the CEO of Sanquin, as recorded in our data.

Sanquin was established in 1998 in Amsterdam, Netherlands, as a foundation in the healthcare sector specializing in blood services. Donors are recruited, and blood is processed into products including red blood cells, platelets, and plasma for direct delivery to hospitals. Research efforts are directed toward transfusion medicine, hematology, immunology, and cell therapy, with partnerships formed alongside national and international academic institutions.

Sanquin offers Blood Products and Diagnostic Services.

Sanquin has 2 investors. Key investors include HHS, and European Union.

Sanquin operates through Sanquin.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available